Evidence map›Paper›PMID 39546122›Full record

ArticleForensic science, medicine, and pathology2025

Blue toe syndrome - systemic cholesterol crystal embolism secondary to cardiovascular procedures: a forensic autopsy report of two cases.

Atsushi Yamada, Kyoka Kiryu, Satoshi Takashino, Masaki Yoshida, Toshiaki Takeichi, Osamu Kitamura

Abstract readCase Reports
In one paragraph

Article in Forensic science, medicine, and pathology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Atsushi YamadaDepartment of Legal Medicine, Kyorin University School of Medicine, 6- 20-2 Shinkawa, Mitaka-shi, Tokyo, 181-8611, Japan. yamalegm@ks.kyorin-u.ac.jp.ORCID 0000-0001-7598-5877
Kyoka KiryuDepartment of Legal Medicine, Kyorin University School of Medicine, 6- 20-2 Shinkawa, Mitaka-shi, Tokyo, 181-8611, Japan.
Satoshi TakashinoDepartment of Legal Medicine, Kyorin University School of Medicine, 6- 20-2 Shinkawa, Mitaka-shi, Tokyo, 181-8611, Japan.
Masaki YoshidaDepartment of Legal Medicine, Kyorin University School of Medicine, 6- 20-2 Shinkawa, Mitaka-shi, Tokyo, 181-8611, Japan.
Toshiaki TakeichiDepartment of Legal Medicine, Kyorin University School of Medicine, 6- 20-2 Shinkawa, Mitaka-shi, Tokyo, 181-8611, Japan.
Osamu KitamuraDepartment of Legal Medicine, Kyorin University School of Medicine, 6- 20-2 Shinkawa, Mitaka-shi, Tokyo, 181-8611, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Blue toe syndrome, also referred to as cholesterol crystal embolism is characterized by the distal embolization of cholesterol crystals originating from ruptured atherosclerotic plaques. This condition commonly arises in the context of cardiovascular procedures. Emboli from the thoracoabdominal aorta primarily affect the downstream extremities and intra-abdominal viscera, often resulting in fatal atheroembolic renal failure. Owing to its insidious and delayed onset, antemortem diagnosis of cholesterol crystal embolism is often underrecognized. Two cases of blue toe syndrome secondary to cardiovascular procedures are presented. In Case 1, the patient died 35 days after coronary angioplasty, whereas in Case 2, the patient developed toe necrosis 95 days after endovascular aortic repair, leading to progressive renal failure over the following five years. A comprehensive forensic autopsy included external examination, skin biopsy, histopathological examination of major organs, and serum biochemical evaluation of renal function parameters. Two cases of blue toe syndrome secondary to cardiovascular procedures are presented. In Case 1, the patient died 35 days after coronary angioplasty, whereas in Case 2, the patient developed toe necrosis 95 days after endovascular aortic repair, leading to progressive renal failure over the following five years. A comprehensive forensic autopsy included external examination, skin biopsy, histopathological examination of major organs, and serum biochemical evaluation of renal function parameters. This report underscores the importance of including systemic cholesterol crystal embolism in the differential diagnosis of blue toe syndrome, particularly in patients with a history of cardiovascular procedures. Fingertips serve as reliable indicators of impaired blood perfusion. To assess blue toe syndrome accurately, we highlight the value of focusing on the toe tips where cholesterol crystal embolism can be consistently detected.

Indexed as

Blue Toe SyndromeEmbolism, CholesterolToesAgedFatal OutcomeFemaleHumansMaleMiddle AgedNecrosisRenal InsufficiencyBlue toe syndromeCardiac catheterizationCholesterol crystal embolismEndovascular aortic repairForensic autopsy

Identifiers

PMID39546122
PMCPMC12325405

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.